Description

3-Oxa-9-Azatricyclo[3.3.1.02,4]Nonane,(1Alpha,2Beta,4Beta,5Alpha)-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex bridged heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in central nervous system (CNS) and antiviral research. It is essential for R&D chemists and process development scientists in the pharmaceutical and biotechnology industries seeking to develop new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug molecules targeting neurological disorders.
• Medicinal Chemistry Research: Used as a scaffold or building block for constructing novel chemical libraries in drug discovery programs.
• Process Chemistry Development: Serves as a critical raw material for optimizing scalable synthetic routes for candidate drugs.
• Active Pharmaceutical Ingredient (API) Synthesis: Incorporated into the final structure of APIs, particularly those with bridged bicyclic or tricyclic architectures.
• Biochemical Research: Potential use as a ligand or probe in studying biological systems and enzyme interactions.
• Contract Manufacturing (CMO): Supplied to contract development and manufacturing organizations (CDMOs) for cGMP production of clinical trial materials.

Basic Information

Product Name	3-Oxa-9-Azatricyclo[3.3.1.02,4]Nonane,(1Alpha,2Beta,4Beta,5Alpha)-(9Ci)
CAS No.	169219-68-5
Molecular Formula	C7H11NO
Molecular Weight	125.17 g/mol
Synonyms	9-Aza-3-oxatricyclo[3.3.1.02,4]nonane, (1α,2β,4β,5α)-; 3-Oxa-9-azatricyclo[3.3.1.0²,⁴]nonane; (1R,2S,4S,5R)-3-Oxa-9-azatricyclo[3.3.1.0²,⁴]nonane; 9-Azatricyclo[3.3.1.0²,⁴]nonan-3-ol, 9-methyl-, ether (stereoisomer); Bridged azetidine-oxolane derivative; NSC 339586; Pharmaceutical Intermediate 169219-68-5.
EINECS	Contact for details

Quality Control

Our 3-Oxa-9-Azatricyclo[3.3.1.02,4]Nonane,(1Alpha,2Beta,4Beta,5Alpha)-(9Ci) is manufactured under strict quality management systems. Each batch is subjected to rigorous analytical testing, including HPLC, GC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment supports development under cGMP guidelines for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.